COSAN (CSAN3) Main Indicators
Basic Data - CSAN3
| Company | COSAN |
| Corporate Name | COSAN S.A. |
| Registration Status | ATIVO |
| Issuer Status | FASE OPERACIONAL |
| Listing Segment | Novo Mercado |
| Activity | Produção de Açúcar. Etanol e Cogeração de Energia. Distribuição de Combustíveis.Produção e Distribuição de Lubrificantes.Tranporte e Carregamento de Açúcar. Operador de Terras e Distribuição de Gás. |
| Share | CSAN3 |
| Quote Date | 04/01/2025 |
| Share Type | ON |
| Last Closing | R$ 7.37 |
| Quotation Factor | 1 Share |
| Financial Volume | R$ 81.06 M |
| Last Statement | DFP - 12/31/2024 |
| Sector | Petróleo. Gás e Biocombustíveis |
| Subsector | Petróleo. Gás e Biocombustíveis |
| Segment | Exploração. Refino e Distribuição |
| Participation Indexes | AGFS, IBOVESPA, IBRA, IBRX, IBRX50, ICO2, IGC, IGCT, IGNM, ISE, ITAG, IVBX, MLCX |
| Updated 04/02/2025 | |
Relative Prices - CSAN3
| Price/Earnings | -1.46 |
| Price/SBV | 1.26 |
| Price/Net Sales | 0.31 |
| Price/CFO | 1.05 |
| Price/FCF | 2.62 |
| Price/Total Assets | 0.10 |
| Price/EBIT | 3.93 |
| Price/Working Capital | 1.07 |
| Price/NCAV | -0.12 |
| EV/EBIT | 19.92 |
| EV/EBITDA | 6.63 |
| EV/Net Sales | 1.59 |
| EV/CFO | 5.34 |
| EV/FCF | 13.31 |
| EV/Total Assets | 0.49 |
| Company Market Cap | R$ 13.76 B |
| Enterprise Value | R$ 69.82 B |
| Current Financial Statement Date | 12/31/2024 |
| Current Share Price | R$ 7.37 |
| Share Price Date | 04/01/2025 |
| Dividend Yield | 6.13% |
| Updated 04/02/2025 | |
Income Statement - CSAN3
| Net Revenue | R$ 43.95 B |
| Gross Result | R$ 13.71 B |
| EBIT | R$ 3.50 B |
| Depreciation and Amortization | - R$ 7.02 B |
| EBITDA | R$ 10.53 B |
| Net Profit | - R$ 9.42 B |
| Net Profit/Share | - R$ 5.05 |
| Updated 03/10/2025 | |
| Net Revenue | R$ 11.77 B |
| Gross Result | R$ 3.41 B |
| EBIT | - R$ 2.89 B |
| Depreciation and Amortization | - R$ 1.44 B |
| EBITDA | - R$ 1.45 B |
| Net Profit | - R$ 9.30 B |
| Profit/Share | - R$ 4.98 |
| Updated 03/10/2025 | |
Price and Volume Behavior - CSAN3
| Lowest Price 52 weeks | R$ 6.91 |
| Highest Price 52 weeks | R$ 15.41 |
| Variation 2025 | -8.10% |
| Variation 1 year | -51.53% |
| Variation 2 years(total) | -48.07% |
| Variation 2 years(yearly) | -27.87% |
| Variation 3 years(total) | -66.32% |
| Variation 3 years(yearly) | -30.40% |
| Variation 4 years(total) | -64.46% |
| Variation 4 years(yearly) | -22.78% |
| Variation 5 years(total) | -32.47% |
| Variation 5 years(yearly) | -7.55% |
| Average Daily Volume (3 months) | R$ 181.66 M |
| Updated 04/02/2025 | |
Returns and Margins - CSAN3
| Return on Initial Tangible Capital | 2.51% |
| Return on Initial Invested Capital | 3.38% |
| Pre-Tax Return on Initial Tangible Capital | 3.81% |
| Pre-Tax Return on Initial Invested Capital | 5.12% |
| Return on Initial Shareholder´s Equity | -44.97% |
| Return on Initial Asset | -6.74% |
| Gross Margin | 31.20% |
| Net Margin | -21.44% |
| EBIT Margin | 7.97% |
| EBITDA Margin | 23.96% |
| Initial Asset Turnover | 0.31 |
| Financial Leverage | 12.96 |
| Liabilities/Net Worth | 11.96 |
| Net Debt/EBITDA | 5.32 |
| Updated 03/10/2025 | |
Balance Sheet - CSAN3
| Cash and Cash Equivalents | R$ 16.90 B |
| Total Assets | R$ 141.27 B |
| Short-Term Debt | R$ 5.41 B |
| Long-Term Debt | R$ 67.55 B |
| Gross Debt | R$ 72.97 B |
| Net Debt | R$ 56.06 B |
| Shareholder´s Equity | R$ 10.90 B |
| Share Book Value | R$ 5.84 |
| Common Shares | 1,866,570,932 |
| Preferred Shares | 0 |
| Total | 1,866,570,932 |
| Common Shares in Treasury | 3,747,965 |
| Preferred Shares in Treasury | 0 |
| Total in Treasury | 3,747,965 |
| Common Shares (Except Treasury) | 1,862,822,967 |
| Preferred Shares (Except Treasury) | 0 |
| Total (Except Treasury) | 1,862,822,967 |
| Updated 03/10/2025 | |
Cash Flow - CSAN3
| Operating Cash Flow | R$ 13.08 B |
| Cash Flow from Investments | - R$ 4.49 B |
| Financing Cash Flow | - R$ 6.61 B |
| Increase (Reduction) in Cash and Equivalents | R$ 2.25 B |
| Updated 03/10/2025 | |
| Operating Cash Flow | R$ 3.70 B |
| Cash Flow from Investments | - R$ 1.37 B |
| Financing Cash Flow | - R$ 194.95 M |
| Increase (Reduction) in Cash and Equivalents | R$ 2.28 B |
| Updated 03/10/2025 | |
Experimental - CSAN3
| CAPEX 3 months | - R$ 2.67 B |
| Free Cash Flow 3 months | R$ 1.03 B |
| CAPEX 12 months | - R$ 7.83 B |
| Free Cash Flow 12 months | R$ 5.25 B |
| Updated 03/10/2025 | |